|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Taxanes in combination with doxorubicin in the treatment of metastatic breast cancer显示文摘 | Dieras V | 1998 | Semin Oncol1998，25，512： | 1 |
| 2 | Correlation of HER2,FCGR2A,and FCGR3A gene polymorphisms with trastuzumab related cardiac toxicity and efficacy in a subgroup of patients from UNICANCER-PACS 04 trial显示文摘 | Roca L Dieras V Roche H | | 0，，： | 1 |
| 3 | Mulficenter phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients 显示文摘 | Blum JL dieras V Lo Russo PM et cd | 2001 | Cancer2001，92，： | 1 |
| 4 | The taxanes: toxicity and quality of life consideration in advanced ovarian cancer显示文摘 | Guastalla JP Dieras V | 2003 | Br J Cancer2003，89，3： | 1 |
| 5 | EGF105084, a phase Ⅱ study of lapatinib for brain metastases in patients with HER2 breast cancer following trastuzumab-based systemic therapy and cranial radiotherapy 显示文摘 | Lin NU Dieras V Paul D | 2007 | Breast Cancer Res Treat2007，106，2721： | 1 |
| 6 | Oxaliplatin and ovarian cancer显示文摘 | Dieras V Girre V Guilhaume MN | 2006 | Bull Cancer2006，93，1： | 1 |
| 7 | The taxanes: toxicity and quality of life consideration in advanced ovarian cancer 显示文摘 | Guastalla JP Dieras V | 2003 | Br J Cancer2003，89，3： | 1 |
| 8 | Multicenter,phaseⅡstudy of capeicitabine in taxane-pretreated metastatic breast carcinoma显示文摘 | Blum J L Dieras V Lo Russo P M | 2012 | Cancer2012，92，7： | 1 |
| 9 | Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer显示文摘 | Pierga JY Mouret E Dieras V | 2000 | Br J Cancer2000，83，11： | 1 |
| 10 | Multicente,phrase II study of eapecitabien in taxane-pretreated metastastic breast carcinoma patients 显示文摘 | Blum JL Dieras V Lo Russo PM | 2001 | Cancer2001，92，： | 1 |
| 11 | RIBBON-1 : ran- domized, double-blind, placebo-controlled, phase III tri- al of chemotherapy with or without bevacizumab for first- line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer 显示文摘 | Robert N J Dieras V Glaspy J | 2011 | J Clin Oncol2011，29，10： | 1 |
| 12 | Muhicenter, phase II study of capecitabine in taxane - pretreated metastatic breast carcinoma patients显示文摘 | Blum JL Dieras V Lo Russo PM | 2001 | Cancer2001，92，7： | 1 |
| 13 | Platinum based chem otherapy in metastatic triple negative breast cancer: the Insti- rut Curie experience显示文摘 | Staudacher L Cottu PH Dieras V | 2011 | Ann Oncol2011，22，4： | 1 |
| 14 | Multicenter,phase Ⅱ study of capecitabine in taxane-pretreated metastatic breast carcinoma patients显示文摘 | Blum JL Dieras V Lo Russo PM | 2001 | Cancer2001，92，7： | 1 |
| 15 | A comparison of jacket and jack-up structural reliability 显示文摘 | DIERA F MORANDI A C SMITH D | 2001 | Marine Structures2001，14，4： | 1 |
| 16 | PhaseⅠtrialof oral mTOR inhibitor everolimus in combination with trastuzumab andvinorelbine in pre-treated patients with HER2-overexpressing metastat-ic breast cancer显示文摘 | Guy Jerusalem Angelica Fasolo Veronique Dieras | 2010 | Breast Cancer Research and Treatment2010，125，： | 1 |
| 17 | The taxanes: Toxicity and quality of life considerations in advanced ovarian 显示文摘 | Guastalla JP Dieras V | 2003 | Br J Cancer2003，89，3： | 1 |
| 18 | Taxanes in combination with doxorubicin in the treatment of metastatic breast cancer显示文摘 | Dieras V | 1998 | Semin Oncol1998，25，12： | 1 |
| 19 | Chemotherapy of metastatic endometral carcinoma,review of the literature显示文摘 | Pierga JY Dieras V Paraiso D | 1995 | Bull Cancer1995，82，： | 1 |
| 20 | Phase Ⅱ multicent rerandomised study of docetaxel plus epirubicin vs 5-fluorouracil plus epirubicin and cyclophosphamide in metastatic breast cancer显示文摘 | BONNETERRE J DIERAS V TUBIANA H M | 2004 | Br J Cancer2004，91，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员